Page last updated: 2024-08-25

oxazolidin-2-one and fidaxomicin

oxazolidin-2-one has been researched along with fidaxomicin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruyère, T; Caspers, P; Keck, W; Knezevic, A; Locher, HH; Pfaff, P; Ritz, D; Schroeder, S1
Clozel, M; Enderlin-Paput, M; Locher, HH; Pfaff, P; Ritz, D; Seiler, P; Weiss, M1
Alam, MJ; Bassères, E; Endres, BT; Garey, KW1
Birchall, S; Corbett, D; Locher, HH; Skinner, K; Thommes, P1

Reviews

1 review(s) available for oxazolidin-2-one and fidaxomicin

ArticleYear
Cadazolid for the treatment of Clostridium difficile.
    Expert opinion on investigational drugs, 2017, Volume: 26, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Lipopeptides; Oxazolidinones; Peptides, Cyclic; Treatment Outcome

2017

Other Studies

3 other study(ies) available for oxazolidin-2-one and fidaxomicin

ArticleYear
Investigations of the mode of action and resistance development of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; DNA Gyrase; Drug Resistance, Bacterial; Fidaxomicin; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Protein Biosynthesis; Recombinant Proteins; RNA; Subcellular Fractions; Transcription, Genetic; Vancomycin

2014
Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Clostridioides difficile; Colony Count, Microbial; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Intestines; Metronidazole; Mice; Microbial Sensitivity Tests; Oxazolidinones; Streptococcal Infections; Treatment Outcome; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci

2016
Time-kill kinetics of cadazolid and comparator antibacterial agents against different ribotypes of Clostridium difficile.
    Journal of medical microbiology, 2018, Volume: 67, Issue:9

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Kinetics; Microbial Sensitivity Tests; Oxazolidinones; Ribotyping; Vancomycin

2018